“Routine Infant Hepatitis B Vaccination Fails to Protect Into Young Adulthood”
![](https://dailyclout.io/wp-content/uploads/hepatatis.jpg)
Originally published on the author’s Substack
Parents Should Not Expect a Long-Term Benefit
In 1991, the Advisory Committee on Immunization Practices (ACIP) first recommended that all infants in the United States receive the hepatitis B vaccine at birth or within 1–2 months of age. The goal was to prevent maternal transmission of the hepatitis B virus (HBV) and reduce the incidence of infections in babies. Many healthy mothers without hepatitis B or risk factors such as IV drug abuse with normal infants ask what is the benefit in their babies?
The CDC recommends that children receive three doses of the hepatitis B vaccine as part of their routine childhood vaccine schedule:
- First dose: Within 24 hours of birth
- Second dose: Between 1–2 months of age
- Third dose: Between 6–18 months of age
What happens later in life when young people go into the medical field and are potentially exposed to hepatitis B in sick patients? Posuwan et al evaluated a prospective cohort of young people (mean age 18 years) going into medicine and evaluated their antibody titers as a proxy of enduring immunity to hepatitis B.
![](https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe8d48c89-28a3-417a-a2ba-b9d29ce217d3_1343x1328.png)
The investigators were disappointed to find that only 6.9% had long-lasting immunity to hepatitis B, and thus underwent booster doses upon entering medical school. It is unclear when immunity is lost in this cohort. The results are important for parents to understand that the hepatitis B shots given at birth are only applicable if the mother has hepatitis B or serious risks for carrying it including active IV drug abuse. Otherwise the vaccine schedule for this illness has little value at that age.
Please Support Our Sponsors
The Wellness Company: https://dailyclouthealth.com
Use code DAILYCLOUT for 10% off!
NativePath: Collagen supplements help you replace what you stop producing — and the studies speak for themselves. Visit https://getnativepath.com/dailyclout for a MASSIVE 45% discount plus free shipping!
Order ‘The Pfizer Papers’ and Support Our Historic Work: https://www.skyhorsepublishing.com/9781648210372/the-pfizer-papers/
Discover LegiSector! Stay up-to-date on issues you care about with LegiSector’s state-of-the-art summarizing capabilities and customizable portals. No researchers needed, no lobbyists, no spin. Legislation at your fingertips! Learn more at https://www.legisector.com/
Subscribe to DailyClout so you never miss an update!
![peter mccullough](https://dailyclout.io/wp-content/uploads/2sbfkc3si015g88b2478smmf8u.jpg)
Dr. McCullough is an internist, cardiologist, epidemiologist managing the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA. Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. Dr. McCullough has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and has been considered among the world’s experts on COVID-19.
One of our country’s most important freedoms is that of free speech.
Agree with this essay? Disagree? Join the debate by writing to DailyClout HERE.